Preprotachykinin A and cholecystokinin mRNAs in tenascingene knockout mouse brain

Neuropeptides

Volumn 31, Issue 2, 1997, Pages 199-201

  Fukamauchi, F ^a   Kusakabe, M ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b RIKEN TSUKUBA INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ; DOPAMINE; MESSENGER RNA; PREPROTACHYKININ; TENASCIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; GENETIC DISORDER; HIPPOCAMPUS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; MAMMALIA;

EID: 0030962459     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(97)90090-1     Document Type: Article

References (12)

1. Faissner A, Schachner M. Tenascin and janusin - glial recognition molecules involved in neural development and regeneration. In: Kettenmann H, Ransom B R, eds. Neuroglial Cells. Oxford: Oxford University Press, 1996.
2. Saga Y, Yagi T, Ikawa Y, Sakakura T, Aizawa S. Mice develop normally without tenascin. Genes Dev 1992; 6: 1821-1831.
3. Fukamauchi F, Mataga N, Wang Y-J, Sato S, Yoshiki A, Kusakabe, M. Abnormal behavior and neurotransmissions of tenascin gene knockout mouse. Biochem Biophys Res Commun 1996; 221: 151-156.
4. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd edn. Sydney: Academic Press, 1986.
5. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
6. Fukamauchi F. Changes in cholecystokinin mRNA expression in methamphetamine-induced behavioral sensitization. Neurochem Int 1996; 28: 391-392.
7. Otsuka M, Yoshioka K. Neurotransmitter functions of mammmalian tachykinins. Physiol Rev 1993; 73: 229-308.
8. Kubota Y, Inagaki S, Kito S. Innervation of substance P neurons by catecholaminergic terminals in the neostriatum. Brain Res 1986; 375: 163-167.
9. Baruch P, Artaud F, Godeheu G, Barbeito L, Glowinski J, Chéramy A. Substance P and neurokinin A regulate by different mechanisms dopamine release from dendrites and nerve terminals of the nigrostriatal dopaminergic neurons. Neuroscience 1988; 25: 889-898.
10. Harro J, Vasar E, Bradwejn J. CCK in animal and human research on anxiety. Trend Pharmacol 1993; 14: 244-249.
11. Hökfelt T, Rehfeld J F, Skirboll L, Ivemark B, Goldstein M, Markey K. Evidence for coexistence of dopamine and CCK in meso-limbic neurons. Nature 1980; 285: 476-478.
12. Yoshikawa T, Shibuya H, Kaneno S, Toru M. Blockade of behavioral sensitization to methamphetamine by lesion of hippocampo-accumbal pathway. Life Sci 1991; 48: 1325-1332.